ArticleBMC cancer2012

JS-K, a glutathione/glutathione S-transferase-activated nitric oxide releasing prodrug inhibits androgen receptor and WNT-signaling in prostate cancer cells.

Martin Laschak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.